Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 9, Issue 2, Pages 360-372Publisher
WILEY
DOI: 10.1111/j.1582-4934.2005.tb00361.x
Keywords
survivin; apoptosis; anticancer drugs; ionizing radiation; antisense oligonucleotides; dominant negative mutants; ribozymes; small interfering RNAs; cycle-dependent kinase inhibitors
Categories
Ask authors/readers for more resources
Survivin is a member of the inhibitor of apoptosis protein (IAP) family, that has been implicated in both control of cell division and inhibition of apoptosis. Specifically, its anti-apoptotic function seems to be related to the ability to directly or indirectly inhibit caspases. Survivin is selectively expressed in the most common human neoplasms and appears to be involved in tumor cell resistance to some anticancer agents and ionizing radiation. On the basis of these findings survivin has been proposed as an attractive target for new anticancer interventions. Several preclinical studies have demonstrated that down-regulation of survivin expression/function, accomplished through the use of antisense oligonucleotides, dominant negative mutants, ribozymes, small interfering RNAs and cyclin-dependent kinase inhibitors, increased the apoptotic rate, reduced tumor-growth potential and sensitized tumor cells to chemotherapeutic drugs with different action mechanisms and gamma-irradiation in in vitro and in vivo models of different human tumor types.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available